Editas Medicine (EDIT) Current Leases (2019 - 2025)

Editas Medicine (EDIT) has 7 years of Current Leases data on file, last reported at $6.0 million in Q4 2025.

• Current Leases for Q4 2025 came in at $6.0 million, down 58.84% year-over-year; the trailing twelve-month figure through Dec 2025 was $6.0 million (down 58.84% YoY), and the FY2025 annual result was $6.0 million, down 58.84% from the prior year.
• Current Leases slipped to $6.0 million in Q4 2025 per EDIT's latest filing, from $6.1 million in the prior quarter.
• Over five years, Current Leases peaked at $18.2 million in Q2 2024 and troughed at $6.0 million in Q4 2025.
• A 5-year average of $10.7 million and a median of $10.3 million in 2021 frame the typical range for Current Leases.
• The sharpest annual moves came in 2024 and 2025: Current Leases soared 76.03% in 2024, then sank 66.2% in 2025.
• A 5-year view of Current Leases shows it stood at $10.3 million in 2021, then grew by 7.5% to $11.1 million in 2022, then increased by 9.76% to $12.2 million in 2023, then grew by 20.45% to $14.7 million in 2024, then sank by 58.84% to $6.0 million in 2025.
• Business Quant data shows EDIT's Current Leases at $6.0 million in Q4 2025, $6.1 million in Q3 2025, and $6.1 million in Q2 2025.